Advertisement
Advertisement
IMDX
I
Insight Molecular Diagnostics Inc. Common Stock
5.01
USDSponsored
+0.05
+1.01%
May 08, 16:00 UTC -4
Closed
After-Market
4.89
-0.12
-2.38%
IMDX Earnings Reports
Positive Surprise Ratio
IMDX beat 15 of 41 last estimates.
37%
Next Report
In 3 Days
Date of Next Report
May 13, 2026
Estimate for Q1 26 (Revenue/ EPS)
$306.00K
/-$0.26
Implied change from Q4 25 (Revenue/ EPS)
-73.13%
/-63.89%
Implied change from Q1 25 (Revenue/ EPS)
-85.69%
/--
Insight Molecular Diagnostics Inc. Common Stock earnings per share and revenue
On Mar 26, 2026, IMDX reported earnings of -0.72 USD per share (EPS) for Q4 25, missing the estimate of -0.24 USD, resulting in a -197.52% surprise. Revenue reached 1.14 million, compared to an expected 295.80 thousand, with a 285.06% difference. The market reacted with a -13.38% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of -0.26 USD, with revenue projected to reach 306.00 thousand USD, implying an decrease of -63.89% EPS, and decrease of -73.13% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Enovis Corporation
Report Date
May 07, 2026 For Q1 26
Estimate
$0.83
Actual
$0.89
Surprise
+6.65%
Clover Health Investments, Corp
Report Date
May 06, 2026 For Q1 26
Estimate
$0.03
Actual
$0.07
Surprise
+128.76%
Claritev Corporation
Report Date
May 07, 2026 For Q1 26
Estimate
-$4.08
Actual
-$4.41
Surprise
-7.90%
Evolent Health, Inc Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.05
Actual
-$0.02
Surprise
+61.39%
KORU Medical Systems, Inc. Common Stock (DE)
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.02
Surprise
+1.96%
CareCloud, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.00
Actual
$0.05
Surprise
+835.29%
American Well Corporation
Report Date
May 05, 2026 For Q1 26
Estimate
-$1.18
Actual
-$0.78
Surprise
+33.98%
Outset Medical, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.81
Actual
-$0.83
Surprise
-2.00%
10x Genomics, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.29
Actual
-$0.10
Surprise
+66.04%
Privia Health Group, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.07
Actual
$0.02
Surprise
-73.72%
FAQ
What were Insight Molecular Diagnostics Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Insight Molecular Diagnostics Inc. Common Stock reported EPS of -$0.72, missing estimates by -197.52%, and revenue of $1.14M, 285.06% above expectations.
How did the market react to Insight Molecular Diagnostics Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -13.38%, changed from $4.11 before the earnings release to $3.56 the day after.
When is Insight Molecular Diagnostics Inc. Common Stock expected to report next?
The next earning report is scheduled for May 13, 2026.
What are the forecasts for Insight Molecular Diagnostics Inc. Common Stock's next earnings report?
Based on 5
analysts, Insight Molecular Diagnostics Inc. Common Stock is expected to report EPS of -$0.26 and revenue of $306.00K for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement